Telix Pharmaceuticals (TLX) Prepaid Assets (2023 - 2026)
Telix Pharmaceuticals (TLX) posted quarterly Prepaid Assets of $16.1 million for Q4 2025, up 16.52% year-over-year from $13.8 million in Q4 2024, and up 16.52% quarter-over-quarter from $13.8 million in Q4 2024.
Analysis
Telix Pharmaceuticals (TLX) Prepaid Assets (2023 - 2026) Analysis & Trends
Telix Pharmaceuticals (TLX) has reported Prepaid Assets for 3 consecutive years, with $16.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 16.52% year-over-year to $16.1 million; the TTM figure through Dec 2025 stood at $16.1 million (up 16.52% YoY), while the FY2025 annual figure was $16.1 million, up 17.8% from the prior year.
- Prepaid Assets improved to $16.1 million in Q4 2025 per TLX's latest filing, from $13.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $16.1 million in Q4 2025 and bottomed at $12.7 million in Q4 2023.
- Historically, Prepaid Assets has averaged $14.2 million across 3 years, with a median of $13.8 million in 2024.
- Annual changes were most pronounced in 2024 — Prepaid Assets rose 8.64% — and 2025, when it gained 16.52%.
- Telix Pharmaceuticals' Prepaid Assets stood at $12.7 million in 2023, then gained by 8.64% to $13.8 million in 2024, then increased by 16.52% to $16.1 million in 2025.
- Business Quant data shows TLX's Prepaid Assets at $16.1 million in Q4 2025, $13.8 million in Q4 2024, and $12.7 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Telix Pharmaceuticals | 4.03 Bn | 3.74 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.69 Mn |
| Dec 31, 2025 | 16.09 Mn |
| Dec 31, 2024 | 13.81 Mn |
| Dec 31, 2023 | 12.71 Mn |